(Q43611763)

English

Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.

scientific article published on 18 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

pharmacokinetics

1 reference

based on heuristic

inferred from title

bioavailability

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Samuel Chao Ming Yeo

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Paul C Ho

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

18 February 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Molecular Nutrition and Food Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

57

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1015-1025

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Pharmacometrics of stilbenes: seguing towards the clinic.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Therapeutic potential of resveratrol: the in vivo evidence

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Resveratrol and health--a comprehensive review of human clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Molecular mechanisms for anti-aging by natural dietary compounds.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene protects vascular endothelial cells against oxidized low-density lipoprotein-induced apoptosis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene, a natural small-molecular compound, promotes cytoprotective macroautophagy in vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene and cancer: current review

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Biological/chemopreventive activity of stilbenes and their effect on colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Antihyperglycemic activity of phenolics from Pterocarpus marsupium

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

The antioxidant role of pterostilbene in streptozotocin-nicotinamide-induced type 2 diabetes mellitus in Wistar rats.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene suppresses benzo[a]pyrene-induced airway remodeling

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene ameliorates tumor necrosis factor alpha-induced pancreatitis in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Inhibitory effects of garcinol and pterostilbene on cell proliferation and adipogenesis in 3T3-L1 cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupium

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene from Vitis coignetiae protect H2O2-induced inhibition of gap junctional intercellular communication in rat liver cell line

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure-activity relationships

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Resveratrol in human cancer chemoprevention--choosing the 'right' dose.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Resveratrol bioavailability and toxicity in humans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: a side-by-side comparison

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Determination of trans-2,4,3',4',5'-pentamethoxystilbene in rat plasma and its application to a pharmacokinetic study.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Quantification of trans-2,6-difluoro-4'-N,N-dimethylaminostilbene in rat plasma: application to a pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Cyclodextrin-based pharmaceutics: past, present and future

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Chemopreventive effects of pterostilbene on urethane-induced lung carcinogenesis in mice via the inhibition of EGFR-mediated pathways and the induction of apoptosis and autophagy

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Oral cancer prevention and control--the approach of the World Health Organization

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200651

21 January 2018

Identifiers

10.1002/MNFR.201200651

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

release_oslzfpcn5jfnderqrzujl6y7y4

1 reference

https://api.fatcat.wiki/v0/release/oslzfpcn5jfnderqrzujl6y7y4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23417986%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43611763&oldid=2101889277"